Forecasting News and Research

RSS

Scientists predict driver mutations of future SARS-CoV-2 variants of concern

A team of scientists from the USA has recently predicted the driver mutations that may appear in future variants of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2). The prediction is based on currently available genetic surveillance data on amino acid mutations present in SARS-CoV-2 variants. A detailed description of the study is currently available on the medRxiv* preprint server.

24 Jun 2021

Inclusion of biological uncertainty, latest data can improve prediction accuracy of epidemic models

The inclusion of biological uncertainty and the latest case data can significantly improve the prediction accuracy of standard epidemiological models of virus transmission, new research led by KAUST and the Kuwait College of Science and Technology (KCST) has shown.

15 Jun 2021

Adapting COVID-19 vaccination strategies based on SARS-CoV-2’s evolution

Given the risk of SARS-CoV-2 developing new variants in unvaccinated individuals, vaccination sites are crucial. However, new research from the University of Michigan, USA, shows current vaccination programs may be worsening regional outbreaks when viral strains and SARS-CoV-2 escape mutations outdo vaccination rates.

15 Jun 2021

Researchers analyze trends to combat discomfort caused by outdoor heat

Rising temperatures are increasingly affecting the quality of life in many regions, setting new challenges for architects, urban planners and healthcare systems. Researchers at KAUST have analyzed discomfort due to outdoor heat across Saudi Arabia and neighboring regions to help understand and combat the problem.

9 Jun 2021

New model predicts which species of soil organisms live in different environments

Though it might seem inanimate, the soil under our feet is very much alive. It's filled with countless microorganisms actively breaking down organic matter, like fallen leaves and plants, and performing a host of other functions that maintain the natural balance of carbon and nutrients stored in the ground beneath us.

7 Jun 2021

Farxiga approved in the US for the treatment of chronic kidney disease in patients at risk of progression with and without type-2 diabetes

Approval is the most significant advancement in the treatment of chronic kidney disease in more than 20 years. In DAPA-CKD Phase III trial, Farxiga demonstrated unprecedented reduction in the risk of the composite of worsening of renal function, end-stage kidney disease and cardiovascular or renal death.

From AstraZeneca 14 May 2021

Prevalence of SARS-CoV-2 antibodies in Germany

Seroprevalence studies have proved their worth in estimating the size and directionality of an outbreak of infectious disease, especially the current pandemic of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2)-induced coronavirus disease 2019 (COVID-19). A new study posted to the medRxiv* preprint server describes the prevalence of SARS-CoV-2 antibodies in five representative regions of Germany.

10 May 2021

WHO and Federal Republic of Germany establish new global hub for pandemic and epidemic intelligence

The World Health Organization (WHO) and the Federal Republic of Germany will establish a new global hub for pandemic and epidemic intelligence, data, surveillance and analytics innovation.

6 May 2021

Computer modeling quantifies the importance of COVID-19 vaccination to control the pandemic

The Mayo Clinic data scientists who developed highly accurate computer modeling to predict trends for COVID-19 cases nationwide have new research that shows how important a high rate of vaccination is to reducing case numbers and controlling the pandemic.

30 Apr 2021

UT Southwestern reports first cases of Brazilian variant of COVID-19 infection in North Texas

UT Southwestern Medical Center scientists have identified the first cases of the Brazilian variant of COVID-19 infection in North Texas using next-generation sequencing technologies along with PCR testing.

26 Apr 2021

The pressure is on to diagnose and treat chronic kidney disease

In this interview, Helen Yeh, the Vice President, Biopharmaceuticals Medical, Cardiovascular, Renal and Metablosim at AstraZeneca , talks News-Medical to about chronic kidney diseas (CKD).

From AstraZeneca 26 Mar 2021

Business Risk Index quantifies the potential risk of COVID-19 transmission

Just one year after the World Health Organization declared the novel coronavirus a global pandemic, three COVID-19 vaccines are available in the United States, and more than 2 million Americans are receiving shots each day.

16 Mar 2021

Study reveals increased hospitalization rates in older adults following tropical cyclones

An increase in overall hospitalizations was reported for older adults in the week following exposure to a tropical cyclone, according to a new study by researchers at Columbia University Mailman School of Public Health, Columbia University's Earth Institute and colleagues at Colorado State University and Harvard T. H. Chan School of Public Health.

9 Mar 2021

Forecasting changes in stock prices based on brain activity

Forecasting changes in stock prices may be possible with the help of brain activity in regions associated with how people feel before making investment choices. Scientists could accurately forecast market price changes based on the average

8 Mar 2021

Report: Probabilistic forecasts of the impact of vaccines and variants on the U.S. COVID trajectory

In a report summary released today Thomas McAndrew, a computational scientist and assistant professor at Lehigh University's College of Health includes probabilistic forecasts of the impact of vaccines and variants on the U.S. COVID trajectory over the next few weeks.

3 Mar 2021

New tool predicts trends and outcomes in individual patients

Clinical research requires that data be mined for insights. Machine learning, which develops algorithms to find patterns, has difficulty doing this with data related to health records because this type of information is neither static nor regularly collected.

26 Feb 2021

International cooperation is key to get equal access to COVID-19 vaccines

Almost 130 countries are yet to receive a single COVID-19 vaccine dose, as ten high-income countries secure the majority.

25 Feb 2021

Experts predict 125,000 fewer COVID deaths if 50% of U.S. population initiate vaccination by March 1

A new report combining forecasting and expert prediction data, predicts that 125,000 lives could be saved by the end of 2021 if 50% or more of the U.S. population initiated COVID vaccination by March 1, 2021.

30 Jan 2021

Wuhan study has important implications for managing COVID-19 pandemic

Researchers in China and the United States have conducted a study assessing the household transmissibility of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) that has important implications for managing the coronavirus disease 2019 (COVID-19) pandemic.

19 Jan 2021

Infectious disease early warning system compensates for existing gaps in surveillance

Researchers at Columbia University Mailman School of Public Health developed an infectious disease early warning system that includes areas lacking health clinics participating in infectious disease surveillance.

11 Jan 2021